CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Director acquired 400,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 400,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- D Other Notice of Sales of Unregistered Securities
- 10-K/A Report 10-K/A
- 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Director acquired 400,000 shares (grant or award)
- 8-K Event Material agreement · Unregistered share sale
- 4 Grant or award Director acquired 400,000 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Material agreement · Unregistered share sale
Page 36 of 63 · 1,250 filings